OMX30 1 618 -1,0%  OMXH25 3 936 -0,3%  OMXC20 1 002 -0,2%  Dow 23 358 -0,4%  Nas 6 315 -0,4%  EUR 9,9259 -0,1%  USD 8,4401 0,2%  Olja 62,5 -0,4%  Guld 1 291 -0,3% 

Biomedical Diagnostics Aktie

<
Kurser + charts + realtid
Kurs & Graf
Graf (stor)
Orderdjup
Realtime push
Börser
>
<
Bolag
Terminer
Profil
>
<
Relaterade värdepapper
ETP:er
Obligationer
>

Fundamentala nyckeltal för Biomedical Diagnostics

2016 2017e 2018e 2019e 2020e
Utdelning - - - - -
Direktavkastning (i %) - - - - -
PE-tal - -12,25 -81,67 18,38 -
Resultat/aktie -0,46 -0,27 -0,13 0,02 -

Nyheter om Biomedical Diagnostics

Inga nyheter tillgängliga
ytterligare nyheter

Analyser om Biomedical Diagnostics

ytterligare analyser

Biomedical Diagnostics Peer Group

pagehit

Lägg till instrument

Vad tycker du?

Profil Biomedical Diagnosticstill bolagsprofilen

Theradiag SA is engaged in the distribution, development and manufacturing of in vitro diagnostic tests. It operates through the following segments: Theranostics and Diagnostics. The Theranostics segment offers solutions for patients treated with anti-tumour necrosis factor alpha. The Diagnostics segment includes products for anti-immunity, genetics, allergy, infectious disease, drug of abuse, other diagnoses, and instrumentation. The company was founded on December 29, 1986 and is headquartered in Croissy-Beaubourg, France.

Till aktien Biomedical Diagnostics

Ticker
ISIN FR0004197747
Index

Biomedical Diagnostics Nyckeltal

Börsvärde i SEK
Free float %
Antal aktier mio. 8,65
Cashflow/aktie i lokal valuta -0,37
Bokvärde/aktie i lokal valuta 0,89
60 dagar vola
PBV